Long-term survival analysis of 191 MAiA® prostheses for trapeziometacarpal arthritis

Surgery for trapeziometacarpal osteoarthritis after failure of medical treatment remains controversial. The aim of this study was to determine the long-term results of the MAiA (R) trapeziometacarpal prosthesis (Lepine, Genay, France). This was a retrospective clinical and radiographic study of 191 MAiA (R) trapeziometacarpal prostheses implanted between 2001 and 2016 from a single centre. The survival rate of the implants at the final follow-up of 12 years (range 17 days to 140 months) was 88%. Median pain score was 1/10. The median Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) score was 20. The rate of major complications was 9% (5% dislocations and 4% loosening) with all dislocations needing revision surgery. The risk of prosthetic dislocation was highest during the first 3 years, most often related to malposition of the trapezium implant. The MAiA trapeziometacarpal prosthesis represents a long-term solution for surgical treatment of thumb rhizarthrosis.